Qt Imaging Holdings (QTI) Cash from Financing Activities (2021 - 2026)
Qt Imaging Holdings' (QTI) quarterly Cash from Financing Activities came in at $159000.0 in Q1 2026, down 97.03% year-on-year from $5.4 million in Q1 2025, and down 98.66% on a QoQ basis from $11.9 million in Q4 2025.
Qt Imaging Holdings (QTI) Cash from Financing Activities (2021 - 2026) Analysis & Trends
Qt Imaging Holdings (QTI) has 6 years of Cash from Financing Activities data on file, last reported at $159000.0 in Q1 2026.
- On a quarterly basis, Cash from Financing Activities fell 97.03% year-over-year to $159000.0 in Q1 2026; TTM through Mar 2026 was $13.2 million, a 160.65% increase from a year earlier, with the FY2025 full-year figure at $18.4 million, up 64.93% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $159000.0, down from $11.9 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for QTI reached as high as $11.9 million in Q4 2025 and fell as low as -$1.2 million in Q3 2024.
- Historically, Cash from Financing Activities has averaged $2.3 million across 5 years, with a median of $623485.0 in 2022.
- Across the five-year window, Cash from Financing Activities slumped 540.06% in 2024 and soared 1709.06% in 2025, its largest moves.
- Year by year, Cash from Financing Activities stood at $675000.0 in 2022, then grew by 18.91% to $802612.0 in 2023, then advanced by 13.07% to $907525.0 in 2024, then surged by 1211.84% to $11.9 million in 2025, then slumped by 98.66% to $159000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were $159000.0 in Q1 2026, $11.9 million in Q4 2025, and $571970.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Qt Imaging Holdings | 33.72 Mn | 26.82 Mn | 2.67 Mn | 159,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 159,000.00 |
| Mar 31, 2026 | 159,000.00 |
| Dec 31, 2025 | 11.91 Mn |
| Dec 31, 2025 | 11.91 Mn |
| Sep 30, 2025 | 571,970.00 |
| Sep 30, 2025 | 571,970.00 |
| Jun 30, 2025 | 523,716.00 |
| Jun 30, 2025 | 523,716.00 |
| Mar 31, 2025 | 5.35 Mn |
| Mar 31, 2025 | 5.35 Mn |
| Dec 31, 2024 | 907,525.00 |
| Dec 31, 2024 | 907,525.00 |
| Sep 30, 2024 | -1.18 Mn |
| Sep 30, 2024 | -1.18 Mn |
| Jun 30, 2024 | -32,548.00 |
| Jun 30, 2024 | -32,548.00 |
| Mar 31, 2024 | 11.43 Mn |
| Mar 31, 2024 | 11.43 Mn |
| Dec 31, 2023 | 802,612.00 |
| Dec 31, 2023 | 802,612.00 |